Genomic Testing in Australia: A Budget Impact Analysis Using Diffusion Modeling From a Healthcare System Perspective
Indication-by-indication funding has yielded slower-than-expected uptake and likely under-budgeting. A first-line genomic testing pathway, aligned with CMA criteria, could better match clinical need while constraining spend versus expanding second-line eligibility. Harmonized eligibility and streamlined implementation would improve access and planning.
Authors
- Adam G. Elshaug (ORCID: https://orcid.org/0000-0002-4939-5379)
- Zornitza Stark (ORCID: https://orcid.org/0000-0001-8640-1371)
- Dylan Mordaunt (ORCID: https://orcid.org/0000-0002-9775-0603)
- Chris Schilling (ORCID: https://orcid.org/0000-0002-1747-7249)
Institutions
- The University of Melbourne (AU)
- Victorian Clinical Genetics Services (AU)
- Melbourne Health (AU)
Publication Details
- Journal
- Value in Health
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.jval.2025.09.3067
- Citations
- 1
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.13